703 filings
Page 4 of 36
8-K
EVFM
Evofem Biosciences, Inc.
10 Mar 23
Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
5:27pm
8-K
EVFM
Evofem Biosciences, Inc.
9 Mar 23
Evofem Biosciences Appoints Interim Chief Financial Officer
4:01pm
D
EVFM
Evofem Biosciences, Inc.
6 Mar 23
$1.38 mm in debt / options, sold $1.38 mm, 4 investors
2:48pm
8-K
EVFM
Evofem Biosciences, Inc.
23 Feb 23
Evofem Biosciences to Explore Strategic Alternatives to Maximize Shareholder Value
8:59pm
8-K
EVFM
Evofem Biosciences, Inc.
23 Feb 23
Entry into a Material Definitive Agreement
3:29pm
DEFA14A
EVFM
Evofem Biosciences, Inc.
16 Feb 23
Additional proxy soliciting materials
9:20pm
8-K
EVFM
Evofem Biosciences, Inc.
16 Feb 23
Departure of Directors or Certain Officers
4:49pm
DEF 14A
EVFM
Evofem Biosciences, Inc.
Definitive proxy
15 Feb 23
4:00pm
SC 13G/A
CVI Investments, Inc.
14 Feb 23
Evofem Biosciences / CVI Investments ownership change
11:24am
D
EVFM
Evofem Biosciences, Inc.
3 Feb 23
$2.31 mm in equity / debt / options, sold $2.31 mm, 8 investors
5:02pm
PRE 14A
EVFM
Evofem Biosciences, Inc.
Preliminary proxy
26 Jan 23
7:10pm
8-K
EVFM
Evofem Biosciences, Inc.
12 Jan 23
Other Events
2:22pm
8-K
EVFM
Evofem Biosciences, Inc.
10 Jan 23
Costco Adds Phexxi® to Member Prescription Program
8:38am
8-K
EVFM
Evofem Biosciences, Inc.
9 Jan 23
Multiple New Insurance Wins Expand and Improve Access to Phexxi® for Millions of Women
11:10am
10-Q
2022 Q3
EVFM
Evofem Biosciences, Inc.
Quarterly report
6 Jan 23
4:53pm
8-K
EVFM
Evofem Biosciences, Inc.
30 Dec 22
Other Events
9:25am
8-K
EVFM
Evofem Biosciences, Inc.
21 Dec 22
Entry into a Material Definitive Agreement
5:27pm
NT 10-Q
EVFM
Evofem Biosciences, Inc.
14 Nov 22
Notice of late quarterly filing
4:31pm
8-K
EVFM
Evofem Biosciences, Inc.
1 Nov 22
Cost Associated with Exit or Disposal Activities
9:06pm
25-NSE
The Nasdaq Stock Market LLC
27 Oct 22
Exchange delisting
9:14am